Literature DB >> 5694748

Mithramycin therapy in disseminated germinal testicular cancer.

N W Ream, C P Perlia, J Wolter, S G Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5694748

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.

Authors:  Tristan M Sissung; Phoebe A Huang; Ralph J Hauke; Edel M McCrea; Cody J Peer; Roberto H Barbier; Jonathan D Strope; Ariel M Ley; Mary Zhang; Julie A Hong; David Venzon; Jonathan P Jackson; Kenneth R Brouwer; Patrick Grohar; Jon Glod; Brigitte C Widemann; Theo Heller; David S Schrump; William D Figg
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

Review 2.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

3.  How mithramycin stereochemistry dictates its structure and DNA binding function.

Authors:  Caixia Hou; Jürgen Rohr; Sean Parkin; Oleg V Tsodikov
Journal:  Medchemcomm       Date:  2019-03-28       Impact factor: 3.597

Review 4.  Acute liver injury.

Authors:  I C Talbot
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

5.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

6.  Structural dissimilarity from self drives neoepitope escape from immune tolerance.

Authors:  Jason R Devlin; Jesus A Alonso; Cory M Ayres; Grant L J Keller; Sara Bobisse; Craig W Vander Kooi; George Coukos; David Gfeller; Alexandre Harari; Brian M Baker
Journal:  Nat Chem Biol       Date:  2020-08-17       Impact factor: 15.040

7.  Quantitative determination of mithramycin in human plasma by a novel, sensitive ultra-HPLC-MS/MS method for clinical pharmacokinetic application.

Authors:  Jeffrey Roth; Cody J Peer; Brigitte Widemann; Diane E Cole; Rachel Ershler; Lee Helman; David Schrump; William D Figg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-09-06       Impact factor: 3.205

8.  Interplay of factors leading to adverse drug reactions in the liver, a personal viewpoint.

Authors:  F Schaffner
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct

9.  Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.

Authors:  Chi-Neu Tsai; Chia-Lung Tsai; Jui-Shan Yi; Huang-Kai Kao; Yenlin Huang; Chun-I Wang; Yun-Shien Lee; Kai-Ping Chang
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

10.  Mithramycin treatment of hypercalcaemia and renal failure in a patient with paratesticular embryonic sarcoma.

Authors:  V Parsons; G Scott; M Baum; E Molland; J Makin
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.